DOI: https://doi.org/10.21897/rmvz.67

Aglepristone efficiency with and without the canine pyometra cloprostenol

Víctor Molina D

Resumen


ABSTRACT

Objective. Evaluate the effectiveness of aglepristone with and without cloprostenol for treating canine pyometra. Materials and methods. Ten female French Bulldogs between 3-8 years of age diagnosed with pyometra were divided into two groups, one receiving a 10 mg/kg dose of aglepristone subcutaneously on days 1, 2, 8, 14 and 28, and the other an equal dose on days 1, 3, 8 and 15, as well as a 1 μg/kg dose of cloprostenol subcutaneously on days 3 and 8. Both groups received 5 mg/kg of enrofloxacin orally every 12 hours for 28 days. Hematic profiles were generated on days 1 and 28 and counted days until the next heat, expelling purulent material and of clinical recuperation. Results. There was no statistical difference in the variables of the line red blood cells between times and protocols. The line of white blood cells showed a statistical difference between days of treatment but not between the two groups. Both treatments were effective resulting in complete clinical recuperation. The combination of aglepristone with cloprostenol acted more quickly, decreasing the number of days of secretion, abdominal pain, and the recuperation of normal activity and appetite. All 10 females were bred during their first heat. Three females from the aglepristone group and one from the combined aglepristone with cloprostenol group were impregnated. Conclusions. Both protocols, combined with enrofloxacin, produced complete clinical recuperation in bitches with pyometra, but it was achieved more rapidly when given the combination of both aglepristone and cloprostenol.

RESUMEN

Objetivo. Evaluar la efectividad del aglepristone con y sin el cloprostenol en el tratamiento del piómetra canino. Materiales y métodos. Diez hembras Bulldog Francés entre 3–8 años de edad con diagnóstico de piómetra, se dividieron en dos grupos, uno recibió aglepristone a la dosis de 10 mg/kg subcutáneo los días 1, 2, 8, 14 y 28, y otro una dosis igual los días 1, 3, 8 y 15, más cloprostenol a dosis de 1 μg/kg subcutáneo los días 3 y 8. Ambos grupos recibieron enrofloxacina 5 mg/kg oral cada 12 horas por 28 días. Se realizaron perfiles hemáticos los días 1 y 28, y se valoraron días de retorno al celo, expulsión del material purulento y de recuperación clínica. Resultados. No hubo diferencia estadística en las variables de la línea roja sanguínea entre tiempos y protocolos. La línea de glóbulos blancos mostró diferencia estadística entre los días de tratamiento pero no entre los dos grupos. Ambos tratamientos fueron eficaces en la recuperación clínica completa, siendo el aglepristone más cloprostenol más rápido en disminuir los días de secreción, dolor abdominal, recuperación de la actividad normal y apetito. Las 10 hembras fueron servidas en el primer celo y quedaron preñadas tres hembras del grupo del aglepristone y una del grupo aglepristone con cloprostenol respectivamente. Conclusiones. Ambos protocolos combinados con enrofloxacina, produjeron la recuperación clínica completa en perras con piómetra, pero se consiguió más rápidamente en el grupo de aglepristone con cloprostenol.


Palabras clave


Antiprogestins; estrogens; endometrial hyperplasia; bitch; progesterone; prostaglandin

Texto completo:

PDF HTML

Referencias


Greene C. Infectious diseases of the dog and cat. Missouri: Elsevier; 2012.

Baithalu RK, Maharana BR, Mishra C, Sarangi L, Samal L. Canine Pyometra. Vet World 2010; 3(7):340–2.

Smith FO. Canine Pyometra. Theriogenology 2006; 66:610–2. http://dx.doi.org/10.1016/j.theriogenology.2006.04.023

Verstegen J, Dhaliwal G, Verstegen-Onclin K. Mucometra, cystic endometrial hyperplasia, and pyometra in the bitch: advances in treatment and assessment of future reproductive success. Theriogenology 2008; 70(3):364–74. http://dx.doi.org/10.1016/j.theriogenology.2008.04.036

Silva-Molano RF, Loaiza-Echeverri AM. Pyometrain small animals. Vet Zootec 2007; 1(2):71–86.

Kempisty B, Bukowska D, Wozna M, Piotrowska H, Jackowaska M, Zuraw A, et al. Endometritis and pyometra in bitches: a review. Vet Med 2013; 58(6):289–97.

Chen YMM, Lee CS, Wright PJ. The roles of progestagen and uterine irritant in the maintenance of cystic endometrial hyperplasia in the canine uterus. Theriogenology 2006; 66(6-7):1537–44. http://dx.doi.org/10.1016/j.theriogenology.2006.01.019

Hiremath S, Sunilchandra U. Non surgical and non hormonal treatment of open pyometra in a bitch under field conditions – A case report. Intas Polivet 2004; 5(11):329–30.

Fossum TW. Cirugía en peque-os animales. Barcelona: Elsevier; 2009.

Nak D, Nak Y, Tuna B. Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone. J Feline Med Surg 2009; 11(6):499–502. http://dx.doi.org/10.1016/j.jfms.2008.09.006

Uçmak M, çagatay T. Comparison of different methods on the medical treatment of cystic endometrial hyperplasia – pyometra complex in bitches. Bull Vet Inst Pulawy 2008; 52(1):231–4.

Jena B, Rao KS, Reddy KCS, Raghavan KBP. Comparative efficacy of various therapeutic protocols in the treatment of pyometra in bitches. Vet Med 2013; 58(5):271–6.

Gobello C, Klima, Lilia, Rodríguez R, Corrada Y, Castexa G. A study of two protocols combining aglepristone and cloprostenol to treat open cervix pyometra in the bitch. Theriogenology 2003; 60:901–8. http://dx.doi.org/10.1016/S0093-691X(03)00094-3

Corrada Y, Arias D, Rodríguez R, Tortora M, Gobello C. Combination dopamine agonist and prostaglandin agonist treatment of cystic endometrial hyperplasia–pyometra complex in the bitch. Theriogenology 2006; 66(6):1557–9. http://dx.doi.org/10.1016/j.theriogenology.2006.01.004

Fieni F. Clinical evaluation of the use of aglepristone, with or without cloprostenol, to treat cystic endometrial hyperplasia pyometra complex in bitches.Theriogenology 2006; 66(1):1550–6. http://dx.doi.org/10.1016/j.theriogenology.2006.02.009

Romagnoli SE, Camillo F, Novellini S, Johnston SD, Cela M. Luteolytic effects of prostaglandin F2alpha on day 8 to 19 corpora lutea in the bitch. Theriogenol. 2006;45(1):397–403.

Polisca, A, Scottia, L, Orlandia, R, Brecchiab, G, Maranesib, M, Zeranic, M, et al. Aglepristone (RU534) administration to non-pregnant bitches in the mid-luteal phase induces early luteal regression. Theriogenology 2010; 74:672–81. http://dx.doi.org/10.1016/j.theriogenology.2010.03.021

Molina VM. Aglepristone como tratamiento del piometra canino. Journal of Agriculture and Animal Sciences 2012; 1(2):86–93.

Bassessar V, Verma Y, Swamy M. Antibiogram of bacterial species isolated from canine pyometra. Vet Word 2013; 6(8):546–9. http://dx.doi.org/10.5455/vetworld.2013.546-549

Trasch K, Wehrend A, Bostedt H. Follow-up examinations of bitches after conservative treatment of pyometra with the antigestagen aglepristone. J Vet Med Physiol Pathol Clin Med 2003; 50(7):375–9. http://dx.doi.org/10.1046/j.1439-0442.2003.00557.x

Jena B, Sadasiva Rao K, Reddy KCS, Raghavan KBP. Physiological and haematological parameters of bitches affected with pyometra. Vet Word 2013; 6(7):409–12. http://dx.doi.org/10.5455/vetworld.2013.409-412

Gogny A, Destrumelle, S, Mallem, Y., Thorin, C, Desfontis, J-C., Gogny, M, et al. In vitro comparison of myometrial contractility induced by aglepristone-oxytocin and aglepristone-PGF2alpha combinations at different stages of the estrus cycle in the bitch. Theriogenology 2010; 74:1531–8. http://dx.doi.org/10.1016/j.theriogenology.2010.06.023

Jurka P, Max, A, Hawry'nski,K, Snochowski, M. Age-Related Pregnancy Results and Further Examination of Bitches after Aglepristone Treatment of Pyometra. Reprod Dom Anim 2010; 45:525–9. http://dx.doi.org/10.1111/j.1439-0531.2008.01288.x

Nak D, Nak Y, Tuna B. Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone. J Feline Med Surg 2009; 11:499–502. http://dx.doi.org/10.1016/j.jfms.2008.09.006

Poci Palumbo MI, da Conceição LC, de Araújo Machado LH, Gomes Lourenço ML, Almeida Moreira S, Legatti E, et al. Toxic acute hepatitis associated to the administration of prostaglandin in a dog. Ciênc Rural 2011; 41(9):1578–81. http://dx.doi.org/10.1590/S0103-84782011005000113

Lika E, Raptil D, Turmalaj L, Gjino P, Robaj A. Medical and Surgical Treatment of Pyometra in Dogs. Maced J Anim Sci 2011; 1(2):391–394.


Métricas de artículo

Cargando métricas ...

Metrics powered by PLOS ALM

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2016 Revista MVZ Córdoba